Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,461 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A phase II randomized trial of cobimetinib plus chemotherapy, with or without atezolizumab, as first-line treatment for patients with locally advanced or metastatic triple-negative breast cancer (COLET): primary analysis.
Brufsky A, Kim SB, Zvirbule Ž, Eniu A, Mebis J, Sohn JH, Wongchenko M, Chohan S, Amin R, Yan Y, McNally V, Miles D, Loi S. Brufsky A, et al. Among authors: kim sb. Ann Oncol. 2021 May;32(5):652-660. doi: 10.1016/j.annonc.2021.01.065. Epub 2021 Feb 1. Ann Oncol. 2021. PMID: 33539944 Free article. Clinical Trial.
Pembrolizumab plus chemotherapy as neoadjuvant treatment of high-risk, early-stage triple-negative breast cancer: results from the phase 1b open-label, multicohort KEYNOTE-173 study.
Schmid P, Salgado R, Park YH, Muñoz-Couselo E, Kim SB, Sohn J, Im SA, Foukakis T, Kuemmel S, Dent R, Yin L, Wang A, Tryfonidis K, Karantza V, Cortés J, Loi S. Schmid P, et al. Among authors: kim sb. Ann Oncol. 2020 May;31(5):569-581. doi: 10.1016/j.annonc.2020.01.072. Epub 2020 Feb 14. Ann Oncol. 2020. PMID: 32278621 Free article. Clinical Trial.
A multicenter, phase II trial of everolimus in locally advanced or metastatic thyroid cancer of all histologic subtypes.
Lim SM, Chang H, Yoon MJ, Hong YK, Kim H, Chung WY, Park CS, Nam KH, Kang SW, Kim MK, Kim SB, Lee SH, Kim HG, Na II, Kim YS, Choi MY, Kim JG, Park KU, Yun HJ, Kim JH, Cho BC. Lim SM, et al. Among authors: kim sb, kim hg, kim h, kim ys, kim jg, kim mk, kim jh. Ann Oncol. 2013 Dec;24(12):3089-94. doi: 10.1093/annonc/mdt379. Epub 2013 Sep 19. Ann Oncol. 2013. PMID: 24050953 Free article. Clinical Trial.
The possible cost effectiveness of peripheral blood stem cell mobilization with cyclophosphamide and the late addition of G-CSF.
Min YJ, Kim SW, Suh C, Park J, Kim HJ, Kim JG, Kim TW, Lee JH, Kim SB, Lee KH, Lee JS, Kim WK, Kim SH. Min YJ, et al. Among authors: kim sb, kim hj, kim tw, kim sw, kim wk, kim sh, kim jg. J Korean Med Sci. 2000 Feb;15(1):49-52. doi: 10.3346/jkms.2000.15.1.49. J Korean Med Sci. 2000. PMID: 10719808 Free PMC article. Clinical Trial.
A case of coincident multiple myeloma and non-Hodgkin's lymphoma.
Lee GC, Hong JS, Lee KH, Kim SB, Kim SW, Suh CW, Lee JS, Chi HS, Kim SH. Lee GC, et al. Among authors: kim sb, kim sw, kim sh. Korean J Intern Med. 1994 Jul;9(2):113-5. doi: 10.3904/kjim.1994.9.2.113. Korean J Intern Med. 1994. PMID: 7865485 Free PMC article. Review.
Acute promyelocytic leukemia is a distinct subset of acute myelocytic leukemia with unique clinicopathologic characteristics including longer duration of relapse free survival: experience in 13 cases.
Lee KH, Kim DH, Lee JS, Suh CW, Kim SW, Kim SB, Lee JH, Doh BS, Chi HS, Lee MS, et al. Lee KH, et al. Among authors: kim sb, kim dh, kim sw. J Korean Med Sci. 1994 Dec;9(6):437-43. doi: 10.3346/jkms.1994.9.6.437. J Korean Med Sci. 1994. PMID: 7786438 Free PMC article.
2,461 results